Rhoshan Pharmaceuticals Inc.
Industry
- Biotechnology
- Pharmaceuticals
- Drug Delivery
See more in Biomedtracker
Latest on Rhoshan Pharmaceuticals Inc.
Generics Bulletin
• By Chloe Kent
Belgian value-added medicines firm Hyloris Pharmaceuticals SA has successfully raised €15.0m ($16.2m) from investors “new and existing, local and international,” through an equity offering by means
Generics Bulletin
• By Chloe Kent
Belgian value-added medicines company Hyloris Pharmaceuticals SA has outlined an ambitious growth strategy while announcing its financial and operational results for the full-year ending 31 December
Scrip
• By Joseph Haas
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Alliances With F-star And Xencor Featur